Cystic Fibrosis in the Era of Precision Medicine: Transformative Progress and Persistent Challenges

Key Points

• The aim is to explore the evolution of cystic fibrosis treatments and the associated challenges in precision medicine.
• Review of advancements in cystic fibrosis therapies over the last decade.
• Analysis of mutation-specific treatment approaches.
• Investigation of the implications of these therapies on patient outcomes.
• Cystic fibrosis treatments have shifted from symptomatic to mutation-specific therapies.
• There remains a gap in addressing all genotypes effectively.
• Despite advancements, challenges in accessibility and managing complex symptoms persist.